Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

N

NEUP

Neuphoria Therapeutics Inc

3.91

Aug 21 • 3:59 PM ET -0.04 (-1.01%)

3.94

Aftermarket • 7:30 PM ET +0.03 (0.77%)

Healthcare Biotechnology USA Nano NASD

Peers: BCDA BIVI CALC CVM KPRX AIM APRE GOVX JAGX KAPA

| Held by: PSIL VTI VXF

Scroll to Statements

Index	-
Market Cap	21.11M
Enterprise Value	1.70M
Income	-
Sales	-
Book/sh	5.47
Cash/sh	3.60
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	8
IPO	Dec 16, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.71
P/C	1.09
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	14.31
Current Ratio	14.31
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-2.43
EPS next Q	-0.56
EPS this Y	-1669.57%
EPS next Y	40.29%
EPS next 5Y	-
EPS past 3/5Y	-17.62% -20.01%
Sales past 3/5Y	334.17% 246.61%
EPS Y/Y TTM	-15957.73%
Sales Y/Y TTM	-
EPS Q/Q	92.44%
Sales Q/Q	-100.00%
Earnings	Jun 03
EPS/Sales Surpr.	0.00% -

Insider Own	9.05%
Insider Trans	0.00%
Inst Own	40.94%
Inst Trans	7.51%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.84%
SMA50	0.69%
SMA200	-9.53%
Trades

Shs Outstand	-
Shs Float	4.92M
Short Float	1.33%
Short Ratio	0.33
Short Interest	0.07M
52W High	21.40 -81.73%
52W Low	3.19 22.57%
Volatility	5.30% 5.14%
ATR (14)	0.20
RSI (14)	52.10
Beta	0.76
Rel Volume	0.91
Avg Volume	197.82K
Volume	179,822

Perf Week	1.03%
Perf Month	-0.26%
Perf Quarter	-23.63%
Perf Half Y	-10.11%
Perf YTD	0.77%
Perf Year	-43.50%
Perf 3Y	-76.28%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	7.00
Prev Close	3.95
Price	3.91
Change %	-1.01%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)